Therapix Biosciences (Israel) Buy Hold or Sell Recommendation

TRPX -- Israel Stock  

null 33.70  0.70  2.12%

Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Therapix Biosciences Ltd is 'Not Rated'. Macroaxis provides Therapix Biosciences buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding TRPX positions. The advice algorithm takes into account all of Therapix Biosciences available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from TRPX buy-and-hold prospective. Also please take a look at World Market Map.

Time Horizon

Risk Tolerance

Execute Advice
Sell Therapix BiosciencesBuy Therapix Biosciences
Not Rated
For the selected time horizon Therapix Biosciences Ltd has a risk adjusted performance of (0.003641), jensen alpha of (0.09), total risk alpha of 0.7098, sortino ratio of 0.0 and treynor ratio of 0.4751
Macroaxis recommendation module can be used to complement Therapix Biosciences buy or sell recommendation provided by average analyst sentiment. It analyzes the firm potential to grow using fundamental, technical, data market data available at the time. Use Therapix Biosciences Net Income, Book Value Per Share, Beta, as well as the relationship between Cash per Share and Earnings Per Share to make sure your buy or sell decision on Therapix Biosciences is adequate.

Therapix Biosciences Returns Distribution Density

Mean Return0.05Value At Risk12.64
Potential Upside7.46Standard Deviation6.44
 Return Density 

Therapix Biosciences Alerts

Trading Alerts and Improvement Suggestions

Therapix Biosciences is not yet fully synchronised with the market data
Therapix Biosciences has high likelihood to experience some financial distress in the next 2 years
The company reported revenue of . Net Loss for the year was (7.66M).
THERAPIX BIO has accumulated about 7.51M in cash with (6.01M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04.
Also please take a look at World Market Map. Please also try Commodity Channel Index module to use commodity channel index to analyze current equity momentum.